Stay updated on CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Sign up to get notified when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.

Latest updates to the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page footer now displays the revision label as v3.4.2, replacing the previous v3.4.1.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page shows a minor revision update from v3.4.0 to v3.4.1, with no changes to study content or essential details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedShow glossary toggle added; Last Update Submitted that Met QC Criteria updated; No FEAR Act Data added; Revision: v3.4.0 displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor backend version change with no impact on study details or user interactions.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (CA, CT, FL, MA, MN, OH, TX, WA) and updated revision to v3.3.3; removed the separate state-location subsections and the HHS Vulnerability Disclosure link (v3.3.2).SummaryDifference1.0%

- Check89 days agoChange DetectedThe page footer shows a revision update from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.